Company / Capital Returned to Shareholders per Share
AGIOS PHARMACEUTICALS, INC. Capital Returned to Shareholders per Share History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
-
FY2023
5-year range
$0.00 / $13.28
FY2019-FY2023
Trend
-
vs FY2022
Sector context
#47 of 51
Health Care
What the data says
Declined from $13.28 to $0.00 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 51
▼
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | - |
| FY2022 | $0.00 | -100.0% |
| FY2021 | $13.28 | - |
| FY2020 | - | - |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026